Moolec Science S.A.
MLEC · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 10.03 | -0.32 | -0.08 |
| FCF Yield | -4.93% | -0.15% | -0.04% | -0.03% |
| EV / EBITDA | -12.42 | -1,041.78 | -367.70 | -1,541.46 |
| Quality | ||||
| ROIC | -5.35% | -26.93% | -47.32% | -99.27% |
| Gross Margin | 34.17% | 8.40% | -15.83% | 0.00% |
| Cash Conversion Ratio | 0.22 | 1.28 | 0.15 | 0.42 |
| Growth | ||||
| Revenue 3-Year CAGR | 617.01% | – | – | -100.00% |
| Free Cash Flow Growth | -217.33% | -23.35% | -307.77% | -21,326.71% |
| Safety | ||||
| Net Debt / EBITDA | -3.57 | -1.51 | -0.00 | 0.26 |
| Interest Coverage | -0.25 | -7.76 | -41.58 | -805.94 |
| Efficiency | ||||
| Inventory Turnover | 98.23 | 0.82 | 2.25 | 0.00 |
| Cash Conversion Cycle | 14.72 | 479.12 | 29.85 | 0.00 |